ConductScience.org, home

Paper19243003

A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.

Alabraba E and 6 others. Liver Transpl, 2009. Cited by 218 papers, by iCite.

Cite this record

ConductScience Library. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Papers, record 19243003. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19243003

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts.
PubMed
Journal
Liver Transpl
PubMed
Year
2009
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
218
iCite
Relative citation ratio, by iCite
6.35
iCite
Revised in PubMed
2022-03-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alabraba EEdward
2Nightingale PPeter
3Gunson BBridget
4Hubscher SStefan
5Olliff SSimon
6Mirza DDarius
7Neuberger JJames

Source PubMed

Download CSV of authors

Topics26

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cholangitis, SclerosingMajor topic
Liver TransplantationMajor topic
Adolescent
Adult
Aged
Cadaver
Colectomy
Female
Follow-Up Studies
Graft Rejection
Graft Survival
HLA Antigens
Humans
Immunosuppressive Agents
Male
Middle Aged
Patient Selection
Recurrence
Retrospective Studies
Risk Factors
Sex Characteristics
Survival Analysis
Survivors
Tissue Donors
Transplantation, Homologous
Young Adult

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in19790228The urgent need for evaluating recurrent primary sclerosing cholangitis in living donor liver transplantation.https://conductscience.org/library/papers/19790228

Source PubMed

Download CSV of comments and corrections

Cited by97

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 218 citations.

PMIDTitleJournalYearIn PapersSource
41997362Microbial Monotherapy With Leuconostoc sp LB-P8 Improves Inflammation and Fibrosis in Mouse Primary Sclerosing Cholangitis by Inhibiting Transforming Growth Factor β1/SMAD Signaling.Cell Mol Gastroenterol Hepatol2026https://conductscience.org/library/papers/41997362PubMed
41857231Distinct phenotype of primary sclerosing cholangitis-associated inflammatory bowel disease.J Gastroenterol2026https://conductscience.org/library/papers/41857231PubMed
41825099Evaluation and management of primary sclerosing cholangitis patients awaiting liver transplantation.JHEP Rep2026https://conductscience.org/library/papers/41825099PubMed
41737226Mortality trends and demographic-geographic disparities of autoimmune liver diseases among U.S. adults aged ≥45 years, 1999-2023.Front Immunol2026https://conductscience.org/library/papers/41737226PubMed
41590547Reply to Mammadov et al. Comment on "Catanzaro et al. Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data. J. Pers. Med. 2024, 14, 222".J Pers Med2026https://conductscience.org/library/papers/41590547PubMed
41406236RIPK1 inhibition reduces biliary injury and fibrosis in primary sclerosing cholangitis.Sci Adv2025https://conductscience.org/library/papers/41406236PubMed
41227212Gut-Liver Axis, Microbiota, Bile Acids, and Immune Response in Pathogenesis of Primary Sclerosing Cholangitis: An Overview.J Clin Med2025https://conductscience.org/library/papers/41227212PubMed
41122155Long-term results of celiac disease patients who underwent liver transplantation.Hepatol Forum2025https://conductscience.org/library/papers/41122155PubMed
40124424All you need to know about the overlap between primary sclerosing cholangitis and inflammatory bowel disease.Ann Gastroenterol2025https://conductscience.org/library/papers/40124424PubMed
40082445Primary sclerosing cholangitis.Nat Rev Dis Primers2025https://conductscience.org/library/papers/40082445PubMed
39888688Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation.Am J Gastroenterol2025https://conductscience.org/library/papers/39888688PubMed
39774274Management of primary sclerosing cholangitis: Current state-of-the-art.Hepatol Commun2024https://conductscience.org/library/papers/39774274PubMed
39679639Outcome of Liver Retransplantation in Patients With Primary Sclerosing Cholangitis.Liver Int2025https://conductscience.org/library/papers/39679639PubMed
39673746Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host-Microbiome-Metabolomic Signatures.J Crohns Colitis2025https://conductscience.org/library/papers/39673746PubMed
39476285Impact of graft type on outcomes following liver transplantation for primary sclerosing cholangitis.Hepatol Int2025https://conductscience.org/library/papers/39476285PubMed
39258375Long-term Outcomes Following Colectomy and Liver Transplantation for Inflammatory Bowel Disease With Primary Sclerosing Cholangitis.Ann Surg2026https://conductscience.org/library/papers/39258375PubMed
39199562The Impact of Biliary Injury on the Recurrence of Biliary Cancer and Benign Disease after Liver Transplantation: Risk Factors and Mechanisms.Cancers (Basel)2024https://conductscience.org/library/papers/39199562PubMed
39167239Ileal pouch-anal anastomosis and end ileostomy result in equivalent graft survival following liver transplantation for inflammatory bowel disease-primary sclerosing cholangitis.Tech Coloproctol2024https://conductscience.org/library/papers/39167239PubMed
38975605Recurrence of Primary Disease After Adult Liver Transplant - Risk Factors, Early Diagnosis, Management, and Prevention.J Clin Exp Hepatol2024https://conductscience.org/library/papers/38975605PubMed
38540965Risk Factors for Recurrence of Primary Sclerosing Cholangitis after Liver Transplantation: Single-Center Data.J Pers Med2024https://conductscience.org/library/papers/38540965PubMed

See all 97 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19243003

GET https://conductscience.org/api/papers/v1/19243003/cited_by?page=2